The Food and Drug Administration posted documents Wednesday finding a single-dose COVID-19 vaccine developed by Johnson & Johnson had a "favorable safety profile with no specific concerns identified that would preclude issuance of an EUA." Read more here: https://fxn.ws/3bBzhVb
